Nano Nuclear Energy (NNE) S-1 21 Oct 24 IPO registration Financial data

Cover

Cover	9 Months Ended
	Jun. 30, 2024
Entity Addresses [Line Items]
Document Type	S-1
Amendment Flag	false
Entity Registrant Name	NANO NUCLEAR ENERGY INC.
Entity Central Index Key	0001923891
Entity Tax Identification Number	88-0861977
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	10 Times Square
Entity Address, Address Line Two	30th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10018
City Area Code	(212)
Local Phone Number	634-9206
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Business Contact [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	10 Times Square
Entity Address, Address Line Two	30th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10018
City Area Code	(212)
Local Phone Number	634-9206
Contact Personnel Name	Nano Nuclear Energy Inc.

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Current assets:
Cash	$ 13,789,532	$ 6,952,795	$ 2,129,999
Prepaid expenses	530,188	205,857	117,448
Total current assets	14,319,720	7,158,652	2,247,447
Deferred offering costs		75,000
Deposits	235,235
Right of use asset	1,872,763
Total assets	16,427,718	7,233,652	2,247,447
Current liabilities:
Accounts payable and accrued liabilities	231,611	190,005	102,771
Lease liability, current	352,281
Contingent consideration	1,222,000
Total current liabilities	1,805,892	225,005
Lease liability, non-current	1,618,510
Total liabilities	3,424,402	225,005	137,771
Mezzanine Equity
Common stock subject to possible redemption		5,000,000
Stockholders’ Equity
Preferred stock value
Common stock value	2,900	2,319	2,050
Additional paid-in capital	27,942,461	9,288,553	3,139,450
Accumulated deficit	(14,942,045)	(7,282,225)	(1,031,824)
Total stockholders’ equity	13,003,316	2,008,647	2,109,676
Total liabilities, mezzanine equity, and stockholders’ equity	16,427,718	7,233,652	2,247,447
Related Party [Member]
Current liabilities:
Due to related parties		$ 35,000	$ 35,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Statement of Financial Position [Abstract]
Treasury stock, common, shares	0	2,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	25,000,000	100,000,000	100,000,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	275,000,000	100,000,000	100,000,000
Common stock, shares issued	29,003,888	23,184,869	20,501,500
Common stock, shares outstanding	29,003,888	23,184,869	20,501,500

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		8 Months Ended	9 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023
Operating expenses
General and administrative	$ 2,301,307	$ 2,038,259	$ 919,520	$ 4,553,512	$ 3,722,232	$ 4,749,395
Research and development	2,019,812	663,144	140,304	2,830,367	1,183,750	1,534,000
Change in Fair Value of contingent consideration	385,500			385,500
Loss from operations	4,706,619	2,701,403	(1,059,824)	7,769,379	4,905,982	(6,283,395)
Other income	38,372	1,753	28,000	109,559	1,753	32,994
Net loss	$ (4,668,247)	$ (2,699,650)	$ (1,031,824)	$ (7,659,820)	$ (4,904,229)	$ (6,250,401)
Net loss per share of common stock:
Basic	$ (0.17)	$ (0.12)	$ (0.06)	$ (0.31)	$ (0.22)	$ (0.28)
Diluted	$ (0.17)	$ (0.12)	$ (0.06)	$ (0.31)	$ (0.22)	$ (0.28)
Weighted-average shares of common stock outstanding:
Basic	27,730,227	22,846,298	16,554,191	24,919,094	22,121,634	22,389,627
Diluted	27,730,227	22,846,298	16,554,191	24,919,094	22,121,634	22,389,627

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Mezzanine Equity and Stockholders' Equity - USD ($)	Temporary Equity [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Permanent Equity, Balance at Feb. 07, 2022
Mezzanine Equity, Balance at Feb. 07, 2022
Mezzanine Equity, Balance, shares at Feb. 07, 2022
Permanent Equity, Balance, shares at Feb. 07, 2022
Equity-based compensation		$ 68	389,932		390,000
Equity-based compensation, shares		675,000
Common stock issuances		$ 1,982	2,749,518		2,751,500
Common stock issuances, shares		19,826,500
Net loss				(1,031,824)	(1,031,824)
Permanent Equity, Balance at Sep. 30, 2022		$ 2,050	3,139,450	(1,031,824)	2,109,676
Mezzanine Equity, Balance at Sep. 30, 2022
Mezzanine Equity, Balance, shares at Sep. 30, 2022
Permanent Equity, Balance, shares at Sep. 30, 2022		20,501,500
Equity-based compensation		$ 9	2,114,005		$ 2,114,014
Equity-based compensation, shares		85,000
Common stock issuances		$ 260	3,765,109		3,765,369
Common stock issuances, shares	2,000,000	2,598,369
Net loss				(4,904,229)	(4,904,229)
Permanent Equity, Balance at Jun. 30, 2023		$ 2,319	9,018,564	(5,936,053)	3,084,830
Mezzanine Equity, Balance at Jun. 30, 2023	$ 5,000,000
Mezzanine Equity, Balance, shares at Jun. 30, 2023	2,000,000
Permanent Equity, Balance, shares at Jun. 30, 2023		23,184,869
Permanent Equity, Balance at Sep. 30, 2022		$ 2,050	3,139,450	(1,031,824)	2,109,676
Mezzanine Equity, Balance at Sep. 30, 2022
Mezzanine Equity, Balance, shares at Sep. 30, 2022
Permanent Equity, Balance, shares at Sep. 30, 2022		20,501,500
Equity-based compensation		$ 9	2,383,994		$ 2,384,003
Equity-based compensation, shares		85,000
Common stock issuances	$ 5,000,000	$ 260	3,765,109		3,765,369
Common stock issuances, shares	2,000,000	2,598,369
Net loss				(6,250,401)	(6,250,401)
Permanent Equity, Balance at Sep. 30, 2023		$ 2,319	9,288,553	(7,282,225)	2,008,647
Mezzanine Equity, Balance at Sep. 30, 2023	$ 5,000,000				$ 5,000,000
Mezzanine Equity, Balance, shares at Sep. 30, 2023	2,000,000				2,000,000
Permanent Equity, Balance, shares at Sep. 30, 2023		23,184,869
Permanent Equity, Balance at Mar. 31, 2023		$ 2,241	5,629,112	(3,236,403)	$ 2,394,950
Mezzanine Equity, Balance at Mar. 31, 2023	$ 5,000,000
Mezzanine Equity, Balance, shares at Mar. 31, 2023	2,000,000
Permanent Equity, Balance, shares at Mar. 31, 2023		22,406,869
Equity-based compensation			1,444,530		1,444,530
Common stock issuances		$ 78	1,944,922		1,945,000
Common stock issuances, shares		778,000
Net loss				(2,699,650)	(2,699,650)
Permanent Equity, Balance at Jun. 30, 2023		$ 2,319	9,018,564	(5,936,053)	3,084,830
Mezzanine Equity, Balance at Jun. 30, 2023	$ 5,000,000
Mezzanine Equity, Balance, shares at Jun. 30, 2023	2,000,000
Permanent Equity, Balance, shares at Jun. 30, 2023		23,184,869
Permanent Equity, Balance at Sep. 30, 2023		$ 2,319	9,288,553	(7,282,225)	2,008,647
Mezzanine Equity, Balance at Sep. 30, 2023	$ 5,000,000				$ 5,000,000
Mezzanine Equity, Balance, shares at Sep. 30, 2023	2,000,000				2,000,000
Permanent Equity, Balance, shares at Sep. 30, 2023		23,184,869
Mezzanine equity conversion		$ 200	4,999,800		$ 5,000,000
Mezzanine equity conversion, shares		2,000,000
Temporary Equity, Mezzanine equity conversion	$ (5,000,000)
Temporary Equity, Mezzanine equity conversion, shares	(2,000,000)
Equity-based compensation			152,457		152,457
Common stock issuances	$ 5,000,000	$ 376	14,253,561		14,253,937
Common stock issuances, shares		3,769,019
Offering costs			(1,538,405)		(1,538,405)
Acquisition common stock issuances		$ 5	786,495		786,500
Acquisition common stock issuances, shares		50,000
Net loss				(7,659,820)	(7,659,820)
Permanent Equity, Balance at Jun. 30, 2024		$ 2,900	27,942,461	(14,942,045)	13,003,316
Mezzanine Equity, Balance at Jun. 30, 2024
Mezzanine Equity, Balance, shares at Jun. 30, 2024					0
Permanent Equity, Balance, shares at Jun. 30, 2024		29,003,888
Permanent Equity, Balance at Mar. 31, 2024		$ 2,601	16,907,165	(10,273,798)	$ 6,635,968
Mezzanine Equity, Balance at Mar. 31, 2024
Mezzanine Equity, Balance, shares at Mar. 31, 2024
Permanent Equity, Balance, shares at Mar. 31, 2024		26,007,013
Common stock issuances		$ 294	11,787,206		11,787,500
Common stock issuances, shares		2,946,875
Offering costs			(1,538,405)		(1,538,405)
Acquisition common stock issuances		$ 5	786,495		786,500
Acquisition common stock issuances, shares		50,000
Net loss				(4,668,247)	(4,668,247)
Permanent Equity, Balance at Jun. 30, 2024		$ 2,900	$ 27,942,461	$ (14,942,045)	13,003,316
Mezzanine Equity, Balance at Jun. 30, 2024
Mezzanine Equity, Balance, shares at Jun. 30, 2024					0
Permanent Equity, Balance, shares at Jun. 30, 2024		29,003,888

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($)	8 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023
OPERATING ACTIVITIES
Net loss	$ (1,031,824)	$ (7,659,820)	$ (4,904,229)	$ (6,250,401)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation	390,000	152,457	2,114,014	2,384,003
Amortization of right of use asset		53,893
R&D acquisition paid in equity		786,500
Change in assets and liabilities:
Prepaid expenses	(117,448)	(324,331)	(38,588)	(88,409)
Deposits		(235,235)
Accounts payable and accrued liabilities	102,771	41,606	147,028	87,234
Due to related parties	35,000	(35,000)	(10,000)
Lease liability		44,135
Contingent liability		1,222,000
Net cash used in operating activities	(621,501)	(5,953,795)	(2,691,775)	(3,867,573)
FINANCING ACTIVITIES
Proceeds from common stock issuances	2,751,500	14,253,937	8,765,369	8,765,369
Offering costs		(1,408,405)
Payment of deferred offering costs		(55,000)	(75,000)	(75,000)
Net cash provided by financing activities	2,751,500	12,790,532	8,690,369	8,690,369
Net increase in cash	2,129,999	6,836,737	5,998,594	4,822,796
Cash, beginning of period		6,952,795	2,129,999	2,129,999
Cash, end of period	$ 2,129,999	13,789,532	8,128,593	$ 6,952,795
Non-cash transactions:
Conversion from Mezzanine Equity to Stockholders’ Equity		(5,000,000)
Inception of Right of Use Asset / Liability		$ 1,926,656

ORGANIZATION AND OPERATIONS AND

ORGANIZATION AND OPERATIONS AND BASIS OF PRESENTATION	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND OPERATIONS AND BASIS OF PRESENTATION	1. ORGANIZATION AND OPERATIONS AND BASIS OF PRESENTATION NANO Nuclear Energy Inc. (“NANO” or the “Company”) was incorporated under the laws of the state of Nevada on February 8, 2022 (“Inception”) and is headquartered in New York, New York. The Company is an early-stage nuclear energy company developing smaller, cheaper, and safer advanced portable clean energy solutions utilizing proprietary reactor designs, intellectual property and research methods. Currently in technical development are “ZEUS”, a solid core battery reactor and “ODIN”, a low-pressure coolant reactor, representing the Company’s first generation of portable, on-demand capable, advanced nuclear micro reactors. The Company envisions readily replaceable mobile reactors which it can provide to customers in several sectors, including data centers, artificial intelligence computer and quantum computing; crypto mining; military applications; disaster relief; transportation (including shipping); mining projects; water desalination and green hydrogen plants; and space exploration. Through its subsidiary, HALEU Energy Fuel Inc., the Company is also developing a domestic High-Assay Low-Enriched Uranium (“HALEU”) fuel fabrication facility with a capability to provide a fuel pipeline for the broader advanced nuclear reactor industry and providing fuel to power the Company’s microreactors. Further, through its subsidiary Advanced Fuel Transportation Inc., the Company is developing a high-capacity HALEU transportation product, capable of moving commercial quantities of HALEU fuel around North America. The Company also plans to offer nuclear service support and consultation services. These condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries American Uranium Inc., HALEU Energy Fuel Inc., and Advanced Fuel Transportation Inc. Each of such subsidiaries is a Nevada corporation. As used herein, the term “Common Stock” refers to the common stock, $ 0.0001 Liquidity These condensed consolidated interim financial statements have been prepared on a going concern basis, which assumes the realization of assets and settlement of liabilities in the normal course of business. At June 30, 2024, the Company had working capital of $ 12,513,828 14,942,045 . For the nine months ended June 30, 2024, the Company had net loss of $ 7,659,820 , and negative cash flows from operations of $ 5,953,795 . At September 30, 2023, the Company had working capital of $ 6,933,647 and accumulated deficit of $ 7,282,225 . For the year ended September 30, 2023, the Company had net loss of $ 6,250,401 , and negative cash flows from operations of $ 3,867,573 . The application of the going concern concept is dependent on the Company’s ability to secure financing from capital markets or other sources, including investors, government grants or alternative funding and, ultimately, on the Company’s ability to generate revenue and profitable operations. Management is of the opinion that sufficient working capital is available to meet the Company’s liabilities and commitments as they come due at least for the next twelve months after the date the condensed consolidated interim financial statements are issued to conform to the going concern uncertainty period. In order to achieve the Company’s long-term strategy, the Company expects to raise additional capital or secure other sources of financing to support its growth. After June 30, 2024, the Company completed an underwritten follow-on public offering generating gross proceeds of approximately $ 18.0 2.70	ORGANIZATION AND OPERATIONS AND BASIS OF PRESENTATION NANO Nuclear Energy Inc. (“NANO” or the “Company”) was incorporated under the laws of the state of Nevada on February 8, 2022 (“Inception”) and is headquartered in New York, NY. The Company intends to progress its collaborative research projects towards development, rigs and models, zero-power reactors, and ultimately towards reactor manufacture and deployments. The Company envisions readily replaceable mobile reactors which it can provide to customers, along with operative personnel, to power projects, residential and commercial enterprises, and major development projects. The Company is committed to providing smaller, cheaper, and safer nuclear energy solutions for the future by incorporating the latest technology into its own proprietary novel reactor designs, intellectual properties, research methods and through its subsidiary, HALEU Energy Fuel Inc. The subsidiary will focus on the future development of a domestic source for a High-Assay Low-Enriched Uranium (HALEU) fuel processing pipeline for the broader advanced nuclear reactor industry and providing fuel to power the Company’s reactors. Currently in technical development are “ZEUS”, a Solid Core Battery Reactor and “ODIN”, a Low-Pressure Coolant Reactor, representing the Company’s first generation of portable, on-demand capable, advanced nuclear micro reactors. These consolidated financial statements include the accounts of the Company and its wholly-owned legal subsidiaries American Uranium Inc., which was incorporated in Nevada, HALEU Energy Fuel Inc., which was incorporated in Nevada and Advanced Fuel Transportation Inc., which was incorporated in Nevada. Liquidity These consolidated financial statements have been prepared on a going concern basis, which assumes the realization of assets and settlement of liabilities in the normal course of business. At September 30, 2023, the Company had working capital of $ 6,933,647 6,250,401 7,282,225 3,867,573 2,109,676 1,031,824 1,031,824 621,501

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim condensed consolidated interim financial statements have been prepared in accordance with U.S. GAAP for interim financial reporting and the rules and regulations of the Securities and Exchange Commission (“SEC”). References to ASC and ASU included herein refer to the Accounting Standards Codification and Accounting Standards Update established by the Financial Accounting Standards Board (“FASB”) as the source of authoritative U.S. GAAP. All intercompany balances and transactions have been eliminated in consolidation. In management’s opinion, the unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company’s annual audited consolidated financial statements. They include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2024, and its results of operations for the three and nine months ended June 30, 2024 and 2023 and cash flows for the nine months ended June 30, 2024 and 2023. The results for the three and nine months ended June 30, 2024 are not necessarily indicative of the results expected for the year or any other periods. The condensed consolidated balance sheet as of September 30, 2023 has been derived from the Company’s audited financial statements. Cash and Cash Equivalents Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase, while cash equivalents with an initial maturity of between three and twelve months at time of purchase are considered short-term investments. The Company’s cash equivalents consist of certificates of deposit, are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost. NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited) Use of Estimates The preparation of condensed consolidated interim financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions made when accounting for items and matters such as, but not limited to, equity-based compensation and contingencies are reasonable, based on information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the condensed consolidated interim financial statements, as well as amounts reported on the statements of operations during the periods presented. Actual results could differ from those estimates. Fair Value Measurement The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach). The levels of hierarchy are described below: Level 1 – Quoted prices in active markets for identical instruments. Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement. The carrying amount of certain financial instruments, including prepaid expenses and accounts payable approximates fair value due to their short maturities. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances at a financial institution and such amounts exceeded federally insured limits at June 30, 2024 and September 30, 2023. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Prepaid Expenses Prepaid expenses primarily relate to payments made to consultants and vendors in advance of the service being provided. Leases The Company recognizes right-of-use (ROU) assets and lease liabilities for leases with terms greater than 12 months. Leases are classified as either finance or operating leases. This classification dictates whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. As of June 30, 2024, the Company has one short-term operating lease and one long-term operating lease. As of September 30, 2023, the Company had one short-term operating lease. Long-term leases (leases with initial terms greater than 12 months) are capitalized at the present value of the minimum lease payments not yet paid. The Company uses its incremental borrowing rate to determine the present value of the lease when the rate implicit in the lease is not readily determinable. Short-term leases (leases with an initial term of 12 months or less or leases that are cancelable by the lessee and lessor without significant penalties) are not capitalized but are expensed on a straight-line basis over the lease term. The Company’s short-term lease relates to office facilities which did not meet the criteria for capitalization as of June 30, 2024 and September 30, 2023. NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited) Mezzanine Equity The Company recognized a tranche of shares of Common Stock as mezzanine equity since such shares were redeemable at the option of the holder, but not mandatorily redeemable. On March 30, 2024, the Company amended its subscription agreement with the holder of such shares to terminate the redemption right, which resulted in a conversion of such shares from mezzanine equity to stockholders’ equity. See Note 5 for further information. Equity-Based Compensation Equity-based compensation is measured using a fair value-based method for all equity-based awards. The cost of awarded equity instruments is recognized based on each instrument’s grant-date fair value over the period during which the award vests. Equity-based compensation is recorded as either a general and administrative expense or a research and development expense in the condensed consolidated statements of operations. Research and Development Research and Development (“R&D”) expenses represent costs incurred for designing and engineering products, including the costs of developing design tools, as well as the costs to acquire technology and other assets from third parties. All research and development costs related to product development are expensed as incurred. Advertising Costs Advertising costs are expensed as incurred and are recognized as a component of general and administrative expenses on the condensed consolidated statements of operations. Advertising costs expensed were $ 227,361 833,589 128,339 305,912 Legal Contingencies The Company is not aware of any pending legal proceedings against the Company. The Company records liabilities for losses from legal proceedings when it determines that it is probable that the outcome in a legal proceeding will be unfavorable, and the amount of loss can be reasonably estimated. Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded when it is “more likely-than-not” that deferred tax assets will not be realized. On a regular basis, the Company evaluates the recoverability of deferred tax assets and the need for a valuation allowance. Such evaluations involve the application of significant judgment. The Company considers multiple factors in its evaluation of the need for a valuation allowance. The Company’s net deferred tax assets consist primarily of assets related to net operating losses. The Company’s net operating losses and credits have an indefinite life for federal net operating losses (“NOLs”) generated through June 30, 2024. At June 30, 2024 and September 30, 2023, the Company recorded a full valuation allowance on its deferred tax assets in the amount of approximately $ 3,580,000 1,971,000 0.0 21 NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited) Until an appropriate level of profitability is attained, the Company expects to maintain a full valuation allowance on its deferred tax assets. Any tax benefits or tax expense recorded on its consolidated statements of operations will be offset with a corresponding valuation allowance until such time that the Company changes its determination related to the realization of deferred tax assets. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such a determination is made. For uncertain tax positions that meet a “more likely-than-not” threshold, the Company recognizes the benefit of uncertain tax positions in the condensed consolidated interim financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the consolidated statements of operations. The Company’s 2023 tax returns remain subject to examination by taxing jurisdictions. At June 30, 2024 and September 30, 2023, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying condensed consolidated interim financial statements. Net Loss per Share Basic net income (loss) per share is computed by dividing net income (loss) attributable to the Company by the weighted average number of shares of Common Stock outstanding during the period. Diluted net income (loss) per share is computed based on the weighted average number of shares of Common Stock outstanding plus the effect of dilutive potential shares of Common Stock outstanding during the period. During the periods when there is a net loss, potentially dilutive shares of Common Stock are excluded from the calculation of diluted net loss per share as their effect is anti-dilutive. During the three and nine months ended June 30, 2024 and 2023, there were no dilutive shares issued or outstanding. Operating Segments For the three and nine months ended June 30, 2024 and 2023, the Company was managed as a single operating segment in accordance with the provisions in the Financial Accounting Standards Board (“FASB”) guidance on segment reporting, which establishes standards for, and requires disclosure of, certain financial information related to reportable operating segments and geographic regions. Furthermore, the Company determined that the Company’s Chairman and President is the Chief Operating Decision Maker as he is responsible for making decisions regarding the allocation of resources and assessing performance as well as for strategic operational decisions and managing the organization as a whole. Recent Accounting Pronouncements The Company considers the applicability and impact of all Accounting Standards Updates issued by the FASB. There are no accounting pronouncements which have been issued but are not yet effective that would have a material impact on our current condensed consolidated interim financial statements.	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of NANO and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions made when accounting for items and matters such as, but not limited to, equity-based compensation and contingencies are reasonable, based on information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, as well as amounts reported on the statements of operations during the periods presented. Actual results could differ from those estimates. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) Fair Value Measurement The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach). The levels of hierarchy are described below: Level 1 – Quoted prices in active markets for identical instruments. Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement. The carrying amount of certain financial instruments, including prepaid expenses and accounts payable approximates fair value due to their short maturities. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances at a financial institution and such amounts exceeded federally insured limits at September 30, 2023 and 2022. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Prepaid Expenses Prepaid expenses primarily relate to payments made to consultants and vendors in advance of the service being provided. Leases The Company recognizes right-of-use assets and lease liabilities for leases with terms greater than 12 months. Leases are classified as either finance or operating leases. This classification dictates whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. As of September 30, 2023 and September 30, 2022, the Company has one short-term operating lease. Long-term leases (leases with initial terms greater than 12 months) are capitalized at the present value of the minimum lease payments not yet paid. The Company uses its incremental borrowing rate to determine the present value of the lease when the rate implicit in the lease is not readily determinable. Short-term leases (leases with an initial term of 12 months or less or leases that are cancelable by the lessee and lessor without significant penalties) are not capitalized but are expensed on a straight-line basis over the lease term. The Company’s short-term lease relates to office facilities which did not meet the criteria for capitalization as of September 30, 2023 and September 30, 2022. Mezzanine Equity The Company recognized a tranche of common shares as mezzanine equity since those common shares may be redeemed at the option of the holder, but is not mandatorily redeemable. Equity-Based Compensation Equity-based compensation is measured using a fair value-based method for all equity-based awards. The cost of awarded equity instruments is recognized based on each instrument’s grant-date fair value over the period during which the award vests. Equity-based compensation is recorded as a general and administrative expense in the statements of operations. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) Research and Development Research and Development (“R&D”) expenses represent costs incurred for designing and engineering products, including the costs of developing design tools. All research and development costs related to product development are expensed as incurred. Advertising Costs Advertising costs are expensed as incurred and are recognized as a component of general and administrative expenses on the consolidated statement of operations. Advertising costs expensed were approximately $ 483,500 13,360 Legal Contingencies The Company is not presently involved in any legal proceedings. The Company records liabilities for losses from legal proceedings when it determines that it is probable that the outcome in a legal proceeding will be unfavorable, and the amount of loss can be reasonably estimated. Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded when it is “more likely-than-not” that deferred tax assets will not be realized. On a regular basis, the Company evaluates the recoverability of deferred tax assets and the need for a valuation allowance. Such evaluations involve the application of significant judgment. The Company considers multiple factors in its evaluation of the need for a valuation allowance. The Company’s net deferred tax assets consist of assets related to net operating losses. The Company’s net operating losses and credits have an indefinite life for federal net operating losses (“NOLs”) generated through September 30, 2023. At September 30, 2023 and 2022, the Company has recorded a full valuation allowance on its deferred tax assets in the amount of approximately $ 1,971,000 281,000 0.0% 21% Until an appropriate level of profitability is attained, the Company expects to maintain a full valuation allowance on its deferred tax assets. Any tax benefits or tax expense recorded on its consolidated statements of operations will be offset with a corresponding valuation allowance until such time that the Company changes its determination related to the realization of deferred tax assets. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such a determination is made. For uncertain tax positions that meet a “more likely-than-not” threshold, the Company recognizes the benefit of uncertain tax positions in the consolidated financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the consolidated statements of operations. The Company’s 2023 tax returns remain subject to examination by taxing jurisdictions. At September 30, 2023 and 2022, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying consolidated financial statements. Net Loss per Share Basic net income (loss) per share is computed by dividing net income (loss) attributable to the Company by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding plus the effect of dilutive potential shares of common stock outstanding during the period. During the periods when there is a net loss, potentially dilutive shares of common stock are excluded from the calculation of diluted net loss per share as their effect is anti-dilutive. During the year ended September 30, 2023, there were no dilutive shares issued or outstanding. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) Operating Segments For the year ended September 30, 2023, the Company was managed as a single operating segment in accordance with the provisions in the Financial Accounting Standards Board (“FASB”) guidance on segment reporting, which establishes standards for, and requires disclosure of, certain financial information related to reportable operating segments and geographic regions. Furthermore, the Company determined that the Company’s Chairman and President is the Chief Operating Decision Maker as he is responsible for making decisions regarding the allocation of resources and assessing performance as well as for strategic operational decisions and managing the organization as a whole. Recent Accounting Pronouncements The Company considers the applicability and impact of all Accounting Standards Updates issued by the FASB. There are no accounting pronouncements which have been issued but are not yet effective that would have a material impact on our current consolidated financial statements.

OTHER INCOME

OTHER INCOME	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2023
Other Income and Expenses [Abstract]
OTHER INCOME	3. OTHER INCOME During the three and nine months ended June 30, 2024, the Company earned interest income of $ 38,372 109,559 1,753	3. OTHER INCOME During the year ended September 30, 2023, the Company earned interest income of $ 32,994 28,000

RELATED PARTIES

RELATED PARTIES	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTIES	4. RELATED PARTIES At June 30, 2024 and September 30, 2023, the Company had amounts due to related parties of $ nil 35,000 345,000 110,000 635,000 315,000 NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited)	4. RELATED PARTIES At September 30, 2023 and September 30, 2022 the Company had amounts due to related parties of $ 35,000 35,000 225,000 90,000 90,000 25,000 25,000 80,000 15,000 30,000 10,000 5,000

EQUITY

EQUITY	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2023
Equity [Abstract]
EQUITY	5. EQUITY The Company is authorized to issue 275,000,000 25,000,000 0.0001 No Common Stock are entitled to one vote per share. Issuance of Common Stock for Cash Incorporation Upon incorporation of the Company, 10,000,000 50,000 Seed Round The Company’s initial round of private financing (the “Seed Round”) began in March 2022 and ended in April 2022. During the period from Inception through September 30, 2022, the Company sold 7,500,000 0.05 375,000 Angel Round The Company’s second round of private financing (the “Angel Round”) began in April 2022 and ended in February 2023. During the period from Inception to September 30, 2022, the Company sold 2,326,500 1.00 2,326,500 1,820,369 1.00 1,820,369 Series A Round The Company’s third round of private financing (the “Series A Round”) began in April 2023 and ended in June 2023. During the year ended September 30, 2023, the Company sold 778,000 2.50 1,945,000 Series B Round The Company’s fourth round of private financing (the “Series B Round”) began in December 2023 and ended in January 2024. As of December 31, 2023, the Company received $ 2,106,437 360,000 822,144 3.00 2,466,437 Initial Public Offering (IPO) On May 7, 2024, the Company consummated a firm commitment underwritten initial public offering (the “IPO Offering”) of an aggregate of 2,562,500 4.00 10,250,000 9,000,000 384,375 1,537,500 1,414,500 179,375 179,375 5.00 1,538,405 Subsequent to June 30, 2024, the Company consummated a firm commitment underwritten follow-on offering. See Note 8 for further information. Mezzanine Equity Pursuant to the terms of a subscription agreement (the “Put Right Subscription Agreement”) signed by the Company during the year ended September 30, 2023 as part of the Series A Round, a subscriber (the “Subscriber”) purchased 2,000,000 2.50 5,000,000 NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited) ASC 480-10-S99-3A provides guidance on the classification and measurement of redeemable securities, which requires classification in temporary equity of securities redeemable for cash or other assets if they are redeemable under certain conditions. One of these conditions is the occurrence of an event that is not solely within the control of the issuer. This condition was applicable up to March 30, 2024, as the Subscriber could have exercised the Put Option and required the Company to redeem the Put Shares since the IPO Registration Statement was not declared effective by the SEC by December 31, 2023. This process involved a significant number of third parties and the SEC’s declaration of effectiveness was ultimately within the SEC’s control. Therefore, this contingently redeemable feature was not considered to be within the control of the Company and was classified within Mezzanine Equity on the accompanying consolidated balance sheet at September 30, 2023. On March 30, 2024, the Subscriber terminated the Put Option at the request of the Company and the amount within Mezzanine Equity was converted to Stockholders’ Equity. Equity-Based Compensation Issuance of Common Stock for Consulting fees During the nine months ended June 30, 2023, the Company issued to two consultants an aggregate of 85,000 85,000 Stock Based Compensation On February 10, 2023, and on June 7, 2023, the Company adopted two distinct stock option plans which are referred to individually, as the 2023 Stock Option Plan #1 and the 2023 Stock Option Plan #2; (collectively, the “2023 Stock Option Plans”). There are 3,370,352 1,758,460 During the nine months ended June 30, 2024, the Company issued 125,000 3.00 125,000 152,457 4.37 1.5 82.5 0 During the year ended September 30, 2023, the Company issued 2,050,000 1.50 1,450,000 200,000 3.00 247,000 60,000 3.00 2,050,000 584,484 4.19 1.5 82.5 0 1,450,000 200,000 1,444,530 4.21 1.5 82.5 0 247,000 60,000 269,989 4.57 1.5 82.5 0 During the nine months ended June 30, 2024 and during the year ended September 30, 2023, the Company’s assumptions utilized in the Black-Scholes valuation were the following: (1) stock price based on recent sales of Common Stock to unrelated parties; (2) estimated the volatility of its underlying stock by using an average of the historical volatility of a group of comparable publicly traded companies; (3) expected dividend yield was calculated using historical dividend amounts; (4) risk-free rate is based on the United States Treasury yield curve in effect at the time of the grant; (5) expected term was estimated based on the vesting and contractual term of the stock option grant. NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited) The weighted average grant date fair value of stock options issued during the nine months ended June 30, 2024 was $ 1.22 no The weighted average grant date fair value of stock options issued during the year ended September 30, 2023 was $ 0.57 no Option Activity A summary of cumulative option activity under the 2023 Plan is as follows: SCHEDULE OF CUMULATIVE OPTION ACTIVITY Options outstanding Number of shares Weighted average exercise price per share Weighted average contractual term (in years) Aggregate intrinsic value (in thousands) Outstanding – September 30, 2023 4,007,000 $ 2.23 2.54 $ 2,004 Options granted 125,000 3.00 2.96 152 Outstanding – June 30, 2024 4,132,000 $ 2.23 2.54 $ 2,156 Vested during the period 125,000 $ 3.00 2.96 $ 152 Vested at end of period - $ - - $ - Exercisable at the end of period 4,132,000 $ 2.26 2.07 $ 2,156 NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited)	5. EQUITY The Company is authorized to issue 100,000,000 0.0001 100,000,000 0.0001 common stock are entitled to one vote per share Issuance of Common Stock for Cash Incorporation Upon incorporation of the Company, 10,000,000 50,000 Seed Round The Seed Round began in March 2022 and ended in April 2022. During the period from Inception through September 30, 2022, the Company sold 7,500,000 0.05 375,000 Angel Round The Angel Round began in April 2022 and ended in February 2023. During period from Inception to September 30, 2022, the Company sold 2,326,500 1.00 2,326,500 1,820,369 1.00 1,820,369 5. EQUITY (Continued) Issuance of Common Stock for Cash (Continued) Series A Round The Series A Round began in April 2023 and ended in June 2023. During the year ended September 30, 2023, the Company sold 778,000 2.50 1,945,000 Series B Round Subsequent to September 30, 2023, the Company sold 822,144 3.00 2,466,437 Mezzanine Equity Pursuant to the terms of a subscription agreement (the “Agreement”) signed by the Company during the year ended September 30, 2023, a subscriber (the “Subscriber”) purchased 2,000,000 2.50 5,000,000 2.50 ASC 480-10-S99-3A provides guidance on the classification and measurement of redeemable securities, which requires classification in temporary equity of securities redeemable for cash or other assets if they are redeemable under certain conditions. One of these conditions is the occurrence of an event that is not solely within the control of the issuer. This condition is applicable as the Subscriber can exercise the Put Option and require the Company to redeem the shares of common stock if the Company’s IPO Registration Statement is not declared effective by the SEC by December 31, 2023. This process involves a significant number of third parties and the SEC’s declaration of effectiveness. Therefore, this contingently redeemable feature is not considered to be within the control of the Company and is classified within Mezzanine Equity on the accompanying consolidated balance sheet at September 30, 2023. As of January 30, 2024, the Subscriber has not exercised the Put Option. Equity-Based Compensation Issuance of Common Stock for Consulting fees During the year ended September 30, 2023, the Company issued to two consultants an aggregate of 85,000 85,000 675,000 390,000 Stock Based Compensation On February 10, 2023, the Company adopted the 2023 Stock Incentive Plan which provides for the grant of incentive stock options and non-qualified stock options to purchase a maximum of 4,974,760 During the year ended September 30, 2023, the Company issued 2,050,000 1.50 1,650,000 3.00 307,000 3.00 2,050,000 584,484 4.19% 1.5 82.5% 0% 1,650,000 1,444,530 4.21% 1.5 82.5% 0% 307,000 269,989 4.57% 1.5 82.5% 0% 5. EQUITY (Continued) Equity-Based Compensation (Continued) Stock Based Compensation (Continued) During the year ended September 30, 2023, the Company’s assumptions utilized in the Black-Scholes valuation were the following: 1) stock price based on recent sales of common stock to unrelated parties; 2) estimated the volatility of its underlying stock by using an average of the historical volatility of a group of comparable publicly traded companies; 3) expected dividend yield was calculated using historical dividend amounts; 4) risk-free rate is based on the United States Treasury yield curve in effect at the time of the grant; 5) expected term was estimated based on the vesting and contractual term of the stock option grant. The weighted average grant date fair value of stock options issued during the year ended September 30, 2023 was $ 0.57 no For the year ended September 30, 2023, $ 1,963,440 420,563 Option Activity A summary of cumulative option activity under the 2023 Plan is as follows: SCHEDULE OF CUMULATIVE OPTION ACTIVITY Options outstanding Weighted average Weighted average Aggregate Number of exercise price contractual term intrinsic value shares per share (in years) (in thousands) Outstanding – September 30, 2022 — $ — — $ — Options granted 2,050,000 1.50 3.00 1,025 Options granted 1,650,000 3.00 3.00 825 Options granted 307,000 3.00 3.00 154 Outstanding – September 30, 2023 4,007,000 $ 2.23 2.54 $ 2,004 Vested during the year 4,007,000 $ 2.23 3.00 $ 2,004 Vested at end of year 4,007,000 $ 2.23 2.54 $ 2,004 Exercisable at the end of the year 4,007,000 $ 2.23 2.54 $ 2,004

RIGHT-OF-USE ASSET AND LEASE LI

RIGHT-OF-USE ASSET AND LEASE LIABILITY	9 Months Ended
	Jun. 30, 2024
Right-of-use Asset And Lease Liability
RIGHT-OF-USE ASSET AND LEASE LIABILITY	6. RIGHT-OF-USE ASSET AND LEASE LIABILITY As of June 30, 2024, the Company has one long-term operating lease for its corporate headquarters located at 10 Times Square, 30th Floor, New York, New York 10018. Lease components in the Company’s long-term operating lease are accounted for following the guidance in ASC 842 for the capitalization of long-term leases. At June 30, 2024, the lease liability is equal to the present value of the remaining lease payments, discounted using a borrowing rate based on similar debt. Lease activity for the three and nine months ended June 30, 2024 and 2023, was as follows: Balance sheet information related to the Company’s leases is presented below: SCHEDULE OF BALANCE SHEET INFORMATION Operating leases: June 30, 2024 September 30, 2023 Operating right-of-use asset $ 1,872,763 $ — Operating lease liability, current 352,281 — Operating lease liability, long-term 1,618,510 — The following provides details of the Company’s lease expense: SCHEDULE OF OTHER INFORMATION RELATED TO LEASES Lease cost: 2024 2023 2024 2023 Three Months Ended June 30, Nine Months Ended June 30, Lease cost: 2024 2023 2024 2023 Operating lease cost $ 103,263 $ — $ 131,632 $ — Other information related to leases is presented below: SCHEDULE OF OTHER INFORMATION RELATED TO LEASES measurement of lease liabilities: 2024 2023 2024 2023 Cash paid for amounts included in the Three Months Ended June 30, Nine Months Ended June 30, measurement of lease liabilities: 2024 2023 2024 2023 Operating cash outflows from operating leases $ 33,605 $ — $ 33,605 $ — June 30, 2024 Weighted-average discount rate – operating lease 13.5 % Weighted-average remaining lease term – operating lease (in years) 7.3 As of June 30, 2024, the expected annual minimum lease payments of the Company’s operating lease liabilities were as follows: SCHEDULE OF EXPECTED ANNUAL MINIMUM LEASE PAYMENTS For the Years Ended September 30, 2024 $ 100,815 2025 339,411 2026 418,508 2027 428,971 2028 439,695 Thereafter 1,306,255 Total future minimum lease payments, undiscounted 3,033,655 Less: Imputed interest for leases in excess of one year (1,062,864 ) Present value of future minimum lease payments 1,970,791 Less: Current portion of lease liabilities (352,281 ) Total lease liabilities less current portion $ 1,618,510 NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited)

ACQUISITION OF ALIP TECHNOLOGY

ACQUISITION OF ALIP TECHNOLOGY	9 Months Ended
	Jun. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
ACQUISITION OF ALIP TECHNOLOGY	7. ACQUISITION OF ALIP TECHNOLOGY On June 21, 2024, the Company acquired a novel annular linear induction pump (“ALIP”) technology used in small nuclear reactor cooling (“ALIP Acquisition”) from noted physicist, research engineer and project manager Carlos O. Maidana, PhD. In connection with the transaction, Dr. Maidana has agreed to collaborate with the Company as a consultant on further development of the ALIP technology with a view towards achieving SBIR Phase III Award status. These efforts will build on previous Department of Energy (“DOE”) grants for the technology aggregating over $ 1.37 350,000 The ALIP SBIR Phase III project acquired by the Company integrates several previous SBIR efforts, specifically: ● Grant Number DE-SC0019835: Development of a Small Electromagnetic Pump for Molten Salt. ● Grant Number DE-SC0022805: Software for Multiphysics Analysis and Design of Annular Linear Induction Pumps. ● Grant Number DE-SC0013992: Computational Tools for the Design of Liquid Metal Thermomagnetic Systems. As part of this transaction, Dr. Maidana assigned to NANO all intellectual property rights associated with the ALIP technology and product, his work on the foregoing grants and the proposal for the SBIR Phase III program. As consideration for the ALIP Acquisition, the Company (i) issued 50,000 50,000 50,000 50,000 The ALIP Acquisition was recorded at its fair value as of June 21, 2024. The total purchase price was approximately $ 1.67 SCHEDULE OF ALIP ACQUISITION Total Cash (paid on closing) $ 50,000 Common shares (issued on closing) 786,500 Contingent cash 50,000 Contingent common shares (fair value at closing) 786,500 Total purchase price $ 1,673,000 As of June 21, 2024, the contingent cash and common shares obligation was recorded at its fair value of $ 836,500 1,222,000 385,500

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	8. SUBSEQUENT EVENTS The Company has evaluated all events or transactions that occurred after June 30, 2024, through the date that the condensed consolidated interim financial statements were issued. During this period, there were no material subsequent events requiring disclosure except as stated as follows: On July 15, 2024, the Company consummated a firm commitment underwritten follow-on public offering (the “Follow-on Offering”) of an aggregate of 900,000 900,000 900,000 450,000 20.00 18.0 135,000 135,0000 67,500 On July 16, 2024, the underwriter exercised the Follow-on Over-allotment Option in full with respect to the Follow-on Over-allotment Shares, and on July 18, 2024, the closing of the purchase of the Follow-on Over-Allotment Shares occurred, generating gross proceeds to the Company of approximately $ 2.70 2.48 Between July 15, 2024 and August 13, 2024, 127,550 63,775 20.00 1,275,500 25,000 25,000 1.50 37,500	6. SUBSEQUENT EVENTS The Company has evaluated all events or transactions that occurred after September 30, 2023 through January 30, 2024, which is the date that the consolidated financial statements were available to be issued. During this period, there were no material subsequent events requiring disclosure except as stated as follows: Subsequent to September 30, 2023, the Company sold 822,144 3.00 2,466,437

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited interim condensed consolidated interim financial statements have been prepared in accordance with U.S. GAAP for interim financial reporting and the rules and regulations of the Securities and Exchange Commission (“SEC”). References to ASC and ASU included herein refer to the Accounting Standards Codification and Accounting Standards Update established by the Financial Accounting Standards Board (“FASB”) as the source of authoritative U.S. GAAP. All intercompany balances and transactions have been eliminated in consolidation. In management’s opinion, the unaudited interim condensed consolidated financial statements have been prepared on the same basis as the Company’s annual audited consolidated financial statements. They include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2024, and its results of operations for the three and nine months ended June 30, 2024 and 2023 and cash flows for the nine months ended June 30, 2024 and 2023. The results for the three and nine months ended June 30, 2024 are not necessarily indicative of the results expected for the year or any other periods. The condensed consolidated balance sheet as of September 30, 2023 has been derived from the Company’s audited financial statements.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase, while cash equivalents with an initial maturity of between three and twelve months at time of purchase are considered short-term investments. The Company’s cash equivalents consist of certificates of deposit, are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost. NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited)
Use of Estimates	Use of Estimates The preparation of condensed consolidated interim financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions made when accounting for items and matters such as, but not limited to, equity-based compensation and contingencies are reasonable, based on information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the condensed consolidated interim financial statements, as well as amounts reported on the statements of operations during the periods presented. Actual results could differ from those estimates.	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions made when accounting for items and matters such as, but not limited to, equity-based compensation and contingencies are reasonable, based on information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, as well as amounts reported on the statements of operations during the periods presented. Actual results could differ from those estimates. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Fair Value Measurement	Fair Value Measurement The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach). The levels of hierarchy are described below: Level 1 – Quoted prices in active markets for identical instruments. Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement. The carrying amount of certain financial instruments, including prepaid expenses and accounts payable approximates fair value due to their short maturities.	Fair Value Measurement The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach). The levels of hierarchy are described below: Level 1 – Quoted prices in active markets for identical instruments. Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement. The carrying amount of certain financial instruments, including prepaid expenses and accounts payable approximates fair value due to their short maturities.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances at a financial institution and such amounts exceeded federally insured limits at June 30, 2024 and September 30, 2023. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances at a financial institution and such amounts exceeded federally insured limits at September 30, 2023 and 2022. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Prepaid Expenses	Prepaid Expenses Prepaid expenses primarily relate to payments made to consultants and vendors in advance of the service being provided.	Prepaid Expenses Prepaid expenses primarily relate to payments made to consultants and vendors in advance of the service being provided.
Leases	Leases The Company recognizes right-of-use (ROU) assets and lease liabilities for leases with terms greater than 12 months. Leases are classified as either finance or operating leases. This classification dictates whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. As of June 30, 2024, the Company has one short-term operating lease and one long-term operating lease. As of September 30, 2023, the Company had one short-term operating lease. Long-term leases (leases with initial terms greater than 12 months) are capitalized at the present value of the minimum lease payments not yet paid. The Company uses its incremental borrowing rate to determine the present value of the lease when the rate implicit in the lease is not readily determinable. Short-term leases (leases with an initial term of 12 months or less or leases that are cancelable by the lessee and lessor without significant penalties) are not capitalized but are expensed on a straight-line basis over the lease term. The Company’s short-term lease relates to office facilities which did not meet the criteria for capitalization as of June 30, 2024 and September 30, 2023. NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited)	Leases The Company recognizes right-of-use assets and lease liabilities for leases with terms greater than 12 months. Leases are classified as either finance or operating leases. This classification dictates whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. As of September 30, 2023 and September 30, 2022, the Company has one short-term operating lease. Long-term leases (leases with initial terms greater than 12 months) are capitalized at the present value of the minimum lease payments not yet paid. The Company uses its incremental borrowing rate to determine the present value of the lease when the rate implicit in the lease is not readily determinable. Short-term leases (leases with an initial term of 12 months or less or leases that are cancelable by the lessee and lessor without significant penalties) are not capitalized but are expensed on a straight-line basis over the lease term. The Company’s short-term lease relates to office facilities which did not meet the criteria for capitalization as of September 30, 2023 and September 30, 2022.
Mezzanine Equity	Mezzanine Equity The Company recognized a tranche of shares of Common Stock as mezzanine equity since such shares were redeemable at the option of the holder, but not mandatorily redeemable. On March 30, 2024, the Company amended its subscription agreement with the holder of such shares to terminate the redemption right, which resulted in a conversion of such shares from mezzanine equity to stockholders’ equity. See Note 5 for further information.	Mezzanine Equity The Company recognized a tranche of common shares as mezzanine equity since those common shares may be redeemed at the option of the holder, but is not mandatorily redeemable.
Equity-Based Compensation	Equity-Based Compensation Equity-based compensation is measured using a fair value-based method for all equity-based awards. The cost of awarded equity instruments is recognized based on each instrument’s grant-date fair value over the period during which the award vests. Equity-based compensation is recorded as either a general and administrative expense or a research and development expense in the condensed consolidated statements of operations.	Equity-Based Compensation Equity-based compensation is measured using a fair value-based method for all equity-based awards. The cost of awarded equity instruments is recognized based on each instrument’s grant-date fair value over the period during which the award vests. Equity-based compensation is recorded as a general and administrative expense in the statements of operations. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Research and Development	Research and Development Research and Development (“R&D”) expenses represent costs incurred for designing and engineering products, including the costs of developing design tools, as well as the costs to acquire technology and other assets from third parties. All research and development costs related to product development are expensed as incurred.	Research and Development Research and Development (“R&D”) expenses represent costs incurred for designing and engineering products, including the costs of developing design tools. All research and development costs related to product development are expensed as incurred.
Advertising Costs	Advertising Costs Advertising costs are expensed as incurred and are recognized as a component of general and administrative expenses on the condensed consolidated statements of operations. Advertising costs expensed were $ 227,361 833,589 128,339 305,912	Advertising Costs Advertising costs are expensed as incurred and are recognized as a component of general and administrative expenses on the consolidated statement of operations. Advertising costs expensed were approximately $ 483,500 13,360
Legal Contingencies	Legal Contingencies The Company is not aware of any pending legal proceedings against the Company. The Company records liabilities for losses from legal proceedings when it determines that it is probable that the outcome in a legal proceeding will be unfavorable, and the amount of loss can be reasonably estimated.	Legal Contingencies The Company is not presently involved in any legal proceedings. The Company records liabilities for losses from legal proceedings when it determines that it is probable that the outcome in a legal proceeding will be unfavorable, and the amount of loss can be reasonably estimated.
Income Taxes	Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded when it is “more likely-than-not” that deferred tax assets will not be realized. On a regular basis, the Company evaluates the recoverability of deferred tax assets and the need for a valuation allowance. Such evaluations involve the application of significant judgment. The Company considers multiple factors in its evaluation of the need for a valuation allowance. The Company’s net deferred tax assets consist primarily of assets related to net operating losses. The Company’s net operating losses and credits have an indefinite life for federal net operating losses (“NOLs”) generated through June 30, 2024. At June 30, 2024 and September 30, 2023, the Company recorded a full valuation allowance on its deferred tax assets in the amount of approximately $ 3,580,000 1,971,000 0.0 21 NANO NUCLEAR ENERGY INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 (Unaudited) Until an appropriate level of profitability is attained, the Company expects to maintain a full valuation allowance on its deferred tax assets. Any tax benefits or tax expense recorded on its consolidated statements of operations will be offset with a corresponding valuation allowance until such time that the Company changes its determination related to the realization of deferred tax assets. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such a determination is made. For uncertain tax positions that meet a “more likely-than-not” threshold, the Company recognizes the benefit of uncertain tax positions in the condensed consolidated interim financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the consolidated statements of operations. The Company’s 2023 tax returns remain subject to examination by taxing jurisdictions. At June 30, 2024 and September 30, 2023, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying condensed consolidated interim financial statements.	Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded when it is “more likely-than-not” that deferred tax assets will not be realized. On a regular basis, the Company evaluates the recoverability of deferred tax assets and the need for a valuation allowance. Such evaluations involve the application of significant judgment. The Company considers multiple factors in its evaluation of the need for a valuation allowance. The Company’s net deferred tax assets consist of assets related to net operating losses. The Company’s net operating losses and credits have an indefinite life for federal net operating losses (“NOLs”) generated through September 30, 2023. At September 30, 2023 and 2022, the Company has recorded a full valuation allowance on its deferred tax assets in the amount of approximately $ 1,971,000 281,000 0.0% 21% Until an appropriate level of profitability is attained, the Company expects to maintain a full valuation allowance on its deferred tax assets. Any tax benefits or tax expense recorded on its consolidated statements of operations will be offset with a corresponding valuation allowance until such time that the Company changes its determination related to the realization of deferred tax assets. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such a determination is made. For uncertain tax positions that meet a “more likely-than-not” threshold, the Company recognizes the benefit of uncertain tax positions in the consolidated financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the consolidated statements of operations. The Company’s 2023 tax returns remain subject to examination by taxing jurisdictions. At September 30, 2023 and 2022, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying consolidated financial statements.
Net Loss per Share	Net Loss per Share Basic net income (loss) per share is computed by dividing net income (loss) attributable to the Company by the weighted average number of shares of Common Stock outstanding during the period. Diluted net income (loss) per share is computed based on the weighted average number of shares of Common Stock outstanding plus the effect of dilutive potential shares of Common Stock outstanding during the period. During the periods when there is a net loss, potentially dilutive shares of Common Stock are excluded from the calculation of diluted net loss per share as their effect is anti-dilutive. During the three and nine months ended June 30, 2024 and 2023, there were no dilutive shares issued or outstanding.	Net Loss per Share Basic net income (loss) per share is computed by dividing net income (loss) attributable to the Company by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding plus the effect of dilutive potential shares of common stock outstanding during the period. During the periods when there is a net loss, potentially dilutive shares of common stock are excluded from the calculation of diluted net loss per share as their effect is anti-dilutive. During the year ended September 30, 2023, there were no dilutive shares issued or outstanding. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Operating Segments	Operating Segments For the three and nine months ended June 30, 2024 and 2023, the Company was managed as a single operating segment in accordance with the provisions in the Financial Accounting Standards Board (“FASB”) guidance on segment reporting, which establishes standards for, and requires disclosure of, certain financial information related to reportable operating segments and geographic regions. Furthermore, the Company determined that the Company’s Chairman and President is the Chief Operating Decision Maker as he is responsible for making decisions regarding the allocation of resources and assessing performance as well as for strategic operational decisions and managing the organization as a whole.	Operating Segments For the year ended September 30, 2023, the Company was managed as a single operating segment in accordance with the provisions in the Financial Accounting Standards Board (“FASB”) guidance on segment reporting, which establishes standards for, and requires disclosure of, certain financial information related to reportable operating segments and geographic regions. Furthermore, the Company determined that the Company’s Chairman and President is the Chief Operating Decision Maker as he is responsible for making decisions regarding the allocation of resources and assessing performance as well as for strategic operational decisions and managing the organization as a whole.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company considers the applicability and impact of all Accounting Standards Updates issued by the FASB. There are no accounting pronouncements which have been issued but are not yet effective that would have a material impact on our current condensed consolidated interim financial statements.	Recent Accounting Pronouncements The Company considers the applicability and impact of all Accounting Standards Updates issued by the FASB. There are no accounting pronouncements which have been issued but are not yet effective that would have a material impact on our current consolidated financial statements.
Principles of Consolidation		Principles of Consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of NANO and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

EQUITY (Tables)

EQUITY (Tables)	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2023
Equity [Abstract]
SCHEDULE OF CUMULATIVE OPTION ACTIVITY	A summary of cumulative option activity under the 2023 Plan is as follows: SCHEDULE OF CUMULATIVE OPTION ACTIVITY Options outstanding Number of shares Weighted average exercise price per share Weighted average contractual term (in years) Aggregate intrinsic value (in thousands) Outstanding – September 30, 2023 4,007,000 $ 2.23 2.54 $ 2,004 Options granted 125,000 3.00 2.96 152 Outstanding – June 30, 2024 4,132,000 $ 2.23 2.54 $ 2,156 Vested during the period 125,000 $ 3.00 2.96 $ 152 Vested at end of period - $ - - $ - Exercisable at the end of period 4,132,000 $ 2.26 2.07 $ 2,156	A summary of cumulative option activity under the 2023 Plan is as follows: SCHEDULE OF CUMULATIVE OPTION ACTIVITY Options outstanding Weighted average Weighted average Aggregate Number of exercise price contractual term intrinsic value shares per share (in years) (in thousands) Outstanding – September 30, 2022 — $ — — $ — Options granted 2,050,000 1.50 3.00 1,025 Options granted 1,650,000 3.00 3.00 825 Options granted 307,000 3.00 3.00 154 Outstanding – September 30, 2023 4,007,000 $ 2.23 2.54 $ 2,004 Vested during the year 4,007,000 $ 2.23 3.00 $ 2,004 Vested at end of year 4,007,000 $ 2.23 2.54 $ 2,004 Exercisable at the end of the year 4,007,000 $ 2.23 2.54 $ 2,004

RIGHT-OF-USE ASSET AND LEASE _2

RIGHT-OF-USE ASSET AND LEASE LIABILITY (Tables)	9 Months Ended
	Jun. 30, 2024
Right-of-use Asset And Lease Liability
SCHEDULE OF BALANCE SHEET INFORMATION	Balance sheet information related to the Company’s leases is presented below: SCHEDULE OF BALANCE SHEET INFORMATION Operating leases: June 30, 2024 September 30, 2023 Operating right-of-use asset $ 1,872,763 $ — Operating lease liability, current 352,281 — Operating lease liability, long-term 1,618,510 —
SCHEDULE OF OTHER INFORMATION RELATED TO LEASES	The following provides details of the Company’s lease expense: SCHEDULE OF OTHER INFORMATION RELATED TO LEASES Lease cost: 2024 2023 2024 2023 Three Months Ended June 30, Nine Months Ended June 30, Lease cost: 2024 2023 2024 2023 Operating lease cost $ 103,263 $ — $ 131,632 $ —
SCHEDULE OF OTHER INFORMATION RELATED TO LEASES	Other information related to leases is presented below: SCHEDULE OF OTHER INFORMATION RELATED TO LEASES measurement of lease liabilities: 2024 2023 2024 2023 Cash paid for amounts included in the Three Months Ended June 30, Nine Months Ended June 30, measurement of lease liabilities: 2024 2023 2024 2023 Operating cash outflows from operating leases $ 33,605 $ — $ 33,605 $ — June 30, 2024 Weighted-average discount rate – operating lease 13.5 % Weighted-average remaining lease term – operating lease (in years) 7.3
SCHEDULE OF EXPECTED ANNUAL MINIMUM LEASE PAYMENTS	As of June 30, 2024, the expected annual minimum lease payments of the Company’s operating lease liabilities were as follows: SCHEDULE OF EXPECTED ANNUAL MINIMUM LEASE PAYMENTS For the Years Ended September 30, 2024 $ 100,815 2025 339,411 2026 418,508 2027 428,971 2028 439,695 Thereafter 1,306,255 Total future minimum lease payments, undiscounted 3,033,655 Less: Imputed interest for leases in excess of one year (1,062,864 ) Present value of future minimum lease payments 1,970,791 Less: Current portion of lease liabilities (352,281 ) Total lease liabilities less current portion $ 1,618,510

ACQUISITION OF ALIP TECHNOLOGY

ACQUISITION OF ALIP TECHNOLOGY (Tables)	9 Months Ended
	Jun. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
SCHEDULE OF ALIP ACQUISITION	The ALIP Acquisition was recorded at its fair value as of June 21, 2024. The total purchase price was approximately $ 1.67 SCHEDULE OF ALIP ACQUISITION Total Cash (paid on closing) $ 50,000 Common shares (issued on closing) 786,500 Contingent cash 50,000 Contingent common shares (fair value at closing) 786,500 Total purchase price $ 1,673,000

ORGANIZATION AND OPERATIONS A_2

ORGANIZATION AND OPERATIONS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended	8 Months Ended	9 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Sep. 30, 2022	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023
Subsidiary, Sale of Stock [Line Items]
Common stock, par value	$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001		$ 0.0001
Working capital	$ 12,513,828		$ 12,513,828	$ 2,109,676	$ 12,513,828		$ 6,933,647
Accumulated deficit	(14,942,045)		(14,942,045)	(1,031,824)	(14,942,045)		(7,282,225)
Net loss	$ (4,668,247)	$ (2,699,650)		(1,031,824)	(7,659,820)	$ (4,904,229)	(6,250,401)
Cash flows from operations				(621,501)	(5,953,795)	(2,691,775)	(3,867,573)
Proceeds			18,000,000	$ 2,751,500	$ 14,253,937	$ 8,765,369	$ 8,765,369
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds			$ 2,700,000

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		8 Months Ended	9 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023
Accounting Policies [Abstract]
Advertising costs	$ 227,361	$ 128,339	$ 13,360	$ 833,589	$ 305,912	$ 483,500
Deferred tax assets valuation allowance	$ 3,580,000		$ 281,000	$ 3,580,000		$ 1,971,000
Effective tax rate	0%	0%	0%	0%	0%	0%
Federal statutory rate	21%	21%	21%	21%	21%	21%

OTHER INCOME (Details Narrative

OTHER INCOME (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023
Other Income and Expenses [Abstract]
Interest income	$ 38,372	$ 1,753	$ 109,559	$ 1,753	$ 32,994
Grants earned					$ 28,000

RELATED PARTIES (Details Narrat

RELATED PARTIES (Details Narrative) - USD ($)	3 Months Ended		8 Months Ended	9 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023
Related Party [Member]
Related Party Transaction [Line Items]
Due to related parties			$ 35,000			$ 35,000
Officers and Directors [Member]
Related Party Transaction [Line Items]
Aggregate compensation paid	$ 345,000	$ 110,000		$ 635,000	$ 315,000
President and Chairman [Member]
Related Party Transaction [Line Items]
Consulting fees			80,000			225,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Consulting fees			15,000			90,000
Chief Financial Officer [Member]
Related Party Transaction [Line Items]
Consulting fees			30,000			90,000
Chief Policy Officer [Member]
Related Party Transaction [Line Items]
Consulting fees			10,000			25,000
Three Independent Directors [Member]
Related Party Transaction [Line Items]
Director fees						$ 25,000
One Independent Directors [Member]
Related Party Transaction [Line Items]
Director fees			$ 5,000

SCHEDULE OF CUMULATIVE OPTION A

SCHEDULE OF CUMULATIVE OPTION ACTIVITY (Details) - USD ($) $ / shares in Units, $ in Thousands	8 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares, outstanding, beginning balance		4,007,000
Weighted average exercise price per share, outstanding, beginning balance		$ 2.23
Weighted average contractual term (in years), outstanding		2 years 6 months 14 days	2 years 6 months 14 days
Aggregate intrinsic value, outstanding, beginning		$ 2,004
Number of shares, granted		125,000
Weighted average exercise price per share, granted		$ 3
Weighted average contractual term (in years), granted		2 years 11 months 15 days
Aggregate intrinsic value, granted		$ 152,000
Number of shares, outstanding, ending balance		4,132,000	4,007,000
Weighted average exercise price per share, outstanding, ending balance		$ 2.23	$ 2.23
Aggregate intrinsic value, outstanding, beginning		$ 2,156	$ 2,004
Number of shares, outstanding, Vested		125,000	4,007,000
Weighted average exercise price per share, vested		$ 3	$ 2.23
Weighted average contractual term (in years), Vested during the period	3 years		2 years 11 months 15 days
Aggregate intrinsic value, Vested during the period		$ 152	$ 2,004
Number of shares, outstanding, Vested at end of period	4,007,000		125,000
Weighted average exercise price per share, Vested at end of period	$ 2.23		$ 3
Aggregate intrinsic value, Vested at end of period	$ 2,004		$ 152
Number of shares, outstanding , Exercisable at the end of period		4,132,000	4,007,000
Weighted average exercise price per share, Exercisable at the end of period		$ 2.26	$ 2.23
Weighted average contractual term (in years), Exercisable at the end of period		2 years 25 days	2 years 6 months 14 days
Aggregate intrinsic value, Exercisable at the end of period		$ 2,156	$ 2,004
Number of shares, outstanding, vested			4,007,000
Weighted average exercise price per share, vested			$ 2.23
Weighted average contractual term (in years), Vested at end of period			2 years 6 months 14 days
Aggregate intrinsic value, Vested at end of period			$ 2,004
Expired on February 10, 2026 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares, granted			2,050,000
Weighted average exercise price per share, granted			$ 1.50
Weighted average contractual term (in years), granted			3 years
Aggregate intrinsic value, granted			$ 1,025,000
Expired on June 7, 2026 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares, granted			1,650,000
Weighted average exercise price per share, granted			$ 3
Weighted average contractual term (in years), granted			3 years
Aggregate intrinsic value, granted			$ 825,000
Expired on August 30, 2026 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares, granted			307,000
Weighted average exercise price per share, granted			$ 3
Weighted average contractual term (in years), granted			3 years
Aggregate intrinsic value, granted			$ 154,000

EQUITY (Details Narrative)

EQUITY (Details Narrative) - USD ($)									1 Months Ended	3 Months Ended		6 Months Ended	8 Months Ended	9 Months Ended			12 Months Ended
	Jul. 16, 2024	Jul. 15, 2024	May 22, 2024	May 07, 2024	Sep. 30, 2023	Jun. 07, 2023	Feb. 10, 2023	Sep. 30, 2022	Jan. 31, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Sep. 30, 2022	Jul. 04, 2024	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023	Aug. 13, 2024	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Feb. 07, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized					100,000,000			100,000,000		275,000,000		275,000,000	100,000,000		275,000,000		100,000,000
Preferred stock, shares authorized					100,000,000			100,000,000		25,000,000		25,000,000	100,000,000		25,000,000		100,000,000
Preferred stock, par value					$ 0.0001			$ 0.0001		$ 0.0001		$ 0.0001	$ 0.0001		$ 0.0001		$ 0.0001
Preferred stock, shares outstanding					0			0		0		0	0		0		0
Common stock, voting rights															Common Stock are entitled to one vote per share.		common stock are entitled to one vote per share
Number of shares issued										$ 11,787,500	$ 1,945,000		$ 2,751,500		$ 14,253,937	$ 3,765,369	$ 3,765,369
Net proceeds												$ 18,000,000	2,751,500		14,253,937	8,765,369	$ 8,765,369
Additional paid in capital issuance costs										1,538,405					1,538,405
Mezzanine equity, shares issued					2,000,000												2,000,000
Mezzanine equity, price per share					$ 2.50												$ 2.50
Mezzanine equity, purchase price					$ 5,000,000												$ 5,000,000
Vested stock options exercisable					$ 2.23					$ 2.23		$ 2.23			$ 2.23		$ 2.23
Risk-free interest rate															4.37%
Expected life of options															1 year 6 months
Estimated volatility															82.50%
Dividend rate															0%
Weighted average fair value of stock options															$ 1.22		$ 0.57
Stock compensation expense															$ 0		$ 0
Common stock, par value					$ 0.0001			0.0001		$ 0.0001		$ 0.0001	$ 0.0001		$ 0.0001		$ 0.0001
Stock based compansation											1,444,530		$ 390,000		$ 152,457	2,114,014	$ 2,384,003
Share based compensation													390,000		152,457	2,114,014	2,384,003
General and Administrative Expense [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation																	1,963,440
Research and Development Expense [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation																	$ 420,563
Twenty Twenty Three Stock Incentive Plan [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock based compansation							$ 4,974,760
Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Mezzanine equity, shares issued					2,000,000												2,000,000
Mezzanine equity, price per share					$ 2.50												$ 2.50
Mezzanine equity, purchase price					$ 5,000,000												$ 5,000,000
Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares purchase of warrants		127,550
Warrant exercise price per share																		$ 20
IPO [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued				2,562,500
Price per share				$ 4
Proceeds from issuance initial public offering				$ 10,250,000
Proceeds from, net of issuance cost				$ 9,000,000
Warrant exercise price per share				$ 5
Additional paid in capital issuance costs										$ 1,538,405					1,538,405
IPO [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued		900,000
Price per share		$ 20
Proceeds from issuance initial public offering		$ 18,000,000
Number of shares purchase of warrants		450,000
Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net proceeds												$ 2,700,000
Number of shares issued				384,375
Proceeds from issuance initial public offering			$ 1,537,500
Proceeds from, net of issuance cost			$ 1,414,500
Number of shares purchase of warrants				179,375
Over-Allotment Option [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued		135,000
Proceeds from issuance initial public offering	$ 2,700,000
Proceeds from, net of issuance cost	$ 2,480,000
Number of shares purchase of warrants		67,500
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued										$ 294	$ 78		$ 1,982		$ 376	$ 260	$ 260
Number of shares issued										2,946,875	778,000		19,826,500		3,769,019	2,598,369	2,598,369
Additional paid in capital issuance costs
Stock options vested number of shares															125,000
Vested stock options exercisable										$ 3		$ 3			$ 3
Stock options vested number of shares, value															$ 152,457
Stock based compansation													$ 68			$ 9	$ 9
Common Stock [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock														822,144
Sale of stock price per share														$ 3
Number of shares purchase of warrants																		63,775
Proceeds from sale of stock														$ 2,466,437
Common Stock [Member] | Expired on June 7, 2026 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock options vested number of shares																	200,000
Common Stock [Member] | Expired on August 30, 2026 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock options vested number of shares																	60,000
Common Stock [Member] | Seed Round [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock													7,500,000
Sale of stock price per share								0.05					$ 0.05
Proceeds from sale of stock													$ 375,000
Common Stock [Member] | Angel Round [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock													2,326,500				1,820,369
Sale of stock price per share					$ 1			$ 1					$ 1				$ 1
Proceeds from sale of stock													$ 2,326,500				$ 1,820,369
Common Stock [Member] | Series A Round [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock																	778,000
Sale of stock price per share					2.50												$ 2.50
Proceeds from sale of stock																	$ 1,945,000
Common Stock [Member] | Series B Round [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock														822,144
Sale of stock price per share														$ 3
Proceeds from sale of stock														$ 2,466,437
Common Stock [Member] | 2023 Stock Option Plan #1 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock available for issuance							3,370,352
Common Stock [Member] | 2023 Stock Option Plan #1 [Member] | Expired on February 10, 2026 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock options vested number of shares																	2,050,000
Vested stock options exercisable					1.50												$ 1.50
Stock options vested number of shares, value																	$ 584,484
Risk-free interest rate																	4.19%
Expected life of options																	1 year 6 months
Estimated volatility																	82.50%
Dividend rate																	0%
Common Stock [Member] | 2023 Stock Option Plan #1 [Member] | Expired on August 30, 2026 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock options vested number of shares																	307,000
Vested stock options exercisable					3												$ 3
Stock options vested number of shares, value																	$ 269,989
Common Stock [Member] | 2023 Stock Option Plan #2 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock available for issuance						1,758,460
Common Stock [Member] | 2023 Stock Option Plan #2 [Member] | Expired on June 7, 2026 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock options vested number of shares																	1,650,000
Vested stock options exercisable					3												$ 3
Stock options vested number of shares, value																	$ 1,444,530
Risk-free interest rate																	4.21%
Expected life of options																	1 year 6 months
Estimated volatility																	82.50%
Dividend rate																	0%
Stock options																	1,450,000
Common Stock [Member] | 2023 Stock Option Plan #2 [Member] | Expired on August 30, 2026 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock options vested number of shares																	247,000
Vested stock options exercisable					$ 3												$ 3
Stock options vested number of shares, value																	$ 269,989
Risk-free interest rate																	4.57%
Expected life of options																	1 year 6 months
Estimated volatility																	82.50%
Dividend rate																	0%
Common Stock [Member] | Private Placement [Member] | Seed Round [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock								7,500,000
Sale of stock price per share								$ 0.05					$ 0.05
Proceeds from issuance of private placement								$ 375,000
Common Stock [Member] | Private Placement [Member] | Angel Round [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock					1,820,369			2,326,500
Sale of stock price per share					$ 1			$ 1					$ 1				$ 1
Proceeds from issuance of private placement					$ 1,820,369			$ 2,326,500
Common Stock [Member] | Private Placement [Member] | Series A Round [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock																	778,000
Sale of stock price per share					$ 2.50												$ 2.50
Proceeds from issuance of private placement																	$ 1,945,000
Common Stock [Member] | Private Placement [Member] | Series B Round [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock									822,144
Sale of stock price per share									$ 3
Proceeds from issuance of private placement									$ 2,466,437
Common stock, value subscriptions									$ 360,000											$ 2,106,437
Common Stock [Member] | IPO [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares purchase of warrants		900,000
Common Stock [Member] | Founder Chairman And President [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued															10,000,000		10,000,000
Net proceeds															50,000		$ 50,000
Common Stock [Member] | Two Consultants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																85,000	85,000
Number of shares issued, value																$ 85,000	$ 85,000
Common Stock [Member] | Consultants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued													675,000
Number of shares issued, value													$ 390,000
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares purchase of warrants				179,375
Warrant [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares purchase of warrants		25,000
Warrant exercise price per share																		$ 1.50
Temporary Equity [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued															5,000,000		$ 5,000,000
Number of shares issued																2,000,000	2,000,000
Mezzanine equity, purchase price					$ 5,000,000						$ 5,000,000					$ 5,000,000	$ 5,000,000				$ 5,000,000
Stock based compansation

SCHEDULE OF BALANCE SHEET INFOR

SCHEDULE OF BALANCE SHEET INFORMATION (Details) - USD ($)	Jun. 30, 2024	Sep. 30, 2023
Right-of-use Asset And Lease Liability
Operating right-of-use asset	$ 1,872,763
Operating lease liability, current	352,281
Operating lease liability, long-term	$ 1,618,510

SCHEDULE OF OTHER INFORMATION R

SCHEDULE OF OTHER INFORMATION RELATED TO LEASES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Right-of-use Asset And Lease Liability
Operating lease cost	$ 103,263		$ 131,632
Operating cash outflows from operating leases	$ 33,605		$ 33,605
Weighted-average discount rate	13.50%		13.50%
Weighted-average remaining lease term	7 years 3 months 18 days		7 years 3 months 18 days

SCHEDULE OF EXPECTED ANNUAL MIN

SCHEDULE OF EXPECTED ANNUAL MINIMUM LEASE PAYMENTS (Details) - USD ($)	Jun. 30, 2024	Sep. 30, 2023
Right-of-use Asset And Lease Liability
2024	$ 100,815
2025	339,411
2026	418,508
2027	428,971
2028	439,695
Thereafter	1,306,255
Total future minimum lease payments, undiscounted	3,033,655
Less: Imputed interest for leases in excess of one year	(1,062,864)
Present value of future minimum lease payments	1,970,791
Less: Current portion of lease liabilities	(352,281)
Total lease liabilities less current portion	$ 1,618,510

SCHEDULE OF ALIP ACQUISITION (D

SCHEDULE OF ALIP ACQUISITION (Details)	Jun. 21, 2024 USD ($)
Business Acquisition [Line Items]
Total purchase price	$ 1,670,000
ALIP Technology [Member]
Business Acquisition [Line Items]
Total purchase price	1,673,000
Cash (paid on closing)	50,000
Common shares (issued on closing)	786,500
Contingent cash	50,000
Contingent common shares (fair value at closing)	$ 786,500

ACQUISITION OF ALIP TECHNOLOG_2

ACQUISITION OF ALIP TECHNOLOGY (Details Narrative) - USD ($)			9 Months Ended
	Jul. 21, 2024	Jun. 21, 2024	Jun. 30, 2024	Sep. 30, 2023
Business Acquisition [Line Items]
Contingent cash		$ 836,500
Contingent consideration			$ 1,222,000
Revaluation expense			$ 385,500
ALIP Technology [Member]
Business Acquisition [Line Items]
Proceeds from previous acquisitions		$ 1,370,000
Number of shares issued for acquisitions		50,000
Business combination cash consideration	$ 50,000
ALIP Technology [Member] | Dr Maidana [Member]
Business Acquisition [Line Items]
Number of shares issued for acquisitions		50,000
Business combination cash consideration	$ 50,000
ALIP Technology [Member] | Dr Maidana [Member] | Consulting Agreement [Member]
Business Acquisition [Line Items]
Proceeds from previous acquisitions		$ 350,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)

1 Months Ended

3 Months Ended

8 Months Ended

9 Months Ended

12 Months Ended

Jul. 16, 2024

Jul. 15, 2024

May 22, 2024

May 07, 2024

Aug. 13, 2024

Jun. 30, 2024

Jun. 30, 2023

Sep. 30, 2022

Jul. 04, 2024

Jun. 30, 2024

Jun. 30, 2023

Sep. 30, 2023

IPO [Member]

Subsequent Event [Line Items]

Number of shares issued

2,562,500

Offering price

$ 4

Gross proceeds

$ 10,250,000

Proceeds from issuance or sale of equity

$ 9,000,000

Warrant exercise price per shares

$ 5

Over-Allotment Option [Member]

Subsequent Event [Line Items]

Warrants to purchase shares

179,375

Number of shares issued

384,375

Warrants to purchase shares

135

Gross proceeds

$ 1,537,500

Proceeds from issuance or sale of equity

$ 1,414,500

Subsequent Event [Member]

Subsequent Event [Line Items]

Warrants to purchase shares

127,550

Warrant exercise price per shares

$ 20

Gross proceeds

$ 1,275,500

Proceeds from stock option exercised

$ 37,500

Subsequent Event [Member] | IPO [Member]

Subsequent Event [Line Items]

Warrants to purchase shares

450,000

Number of shares issued

900,000

Warrants to purchase shares

900,000

Offering price

$ 20

Gross proceeds

$ 18,000,000

Subsequent Event [Member] | Over-Allotment Option [Member]

Subsequent Event [Line Items]

Warrants to purchase shares

67,500

Number of shares issued

135,000

Gross proceeds

$ 2,700,000

Proceeds from issuance or sale of equity

$ 2,480,000

Subsequent Event [Member] | Equity Option [Member]

Subsequent Event [Line Items]

Warrants to purchase shares

25,000

Common Stock [Member]

Subsequent Event [Line Items]

Number of shares issued

2,946,875

778,000

19,826,500

3,769,019

2,598,369

2,598,369

Common Stock [Member] | Subsequent Event [Member]

Subsequent Event [Line Items]

Warrants to purchase shares

63,775

Sale of stock

822,144

Sale of stock, price per share

$ 3

Gross proceeds from sale of stock

$ 2,466,437

Common Stock [Member] | Subsequent Event [Member] | IPO [Member]

Subsequent Event [Line Items]

Warrants to purchase shares

900,000

Warrant [Member]

Subsequent Event [Line Items]

Warrants to purchase shares

179,375

Warrant [Member] | Subsequent Event [Member]

Subsequent Event [Line Items]

Warrants to purchase shares

25,000

Warrant exercise price per shares

$ 1.50